$70M immunotherapy startup launches with backing from Pfizer, Astellas


The venture arms of life sciences giants and a biotech real estate developer are backing a brand-new startup launched by the Longwood Fund.

Previous Business of Pride Awards 2022: Dr. Anthony Dao leads LGBTQIA+ advocacy program at Wash U
Next 2022 Diversity in Business Awards: How 26Health strives to create equity in the Orlando area's patient populations